-1.78%
Today
Loading 1D prices…
Company profile
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Baudette, MN, United States
Employees
970
Fiscal year end
1231
CIK
1023024
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| SNDXSyndax Pharmaceuticals Inc. Common Stock | $1.6B | $172.4M | -165.59% | -$3.29 | -3.29% | Buy |
| ANABAnaptysBio Inc. Common Stock | $1.6B | $234.6M | -5.64% | -$0.46 | -2.37% | Buy |
| ETONEton Pharmaceuticals Inc. Common Stock | $1.6B | $80M | -5.75% | -$0.17 | -1.38% | Buy |
| BCAXBicara Therapeutics Inc. Common Stock | $1.5B | $0.00 | — | -$2.52 | -1.17% | Buy |
| AAPGAscentage Pharma Group International American Depository Shares | $1.5B | — | — | -$13.96 | -3.42% | Buy |